Twice each month the CEA Registry Blog lists recently published cost utility studies and associated papers. From the ones listed this time, here's a few in our areas of research interest:
Mihalopoulos C, Chen G, Iezzi A, et. al. Assessing outcomes for cost-utility analysis in depression: comparison of five multi-attribute utility instruments with two depression-specific outcome measures. Br J Psychiatry. 2014 Sep 25. [Epub ahead of print] PubMed PMID: 25257063.
Bock JA, Fairley KJ, Smith RE, et. al. Cost-Effectiveness of IL28? Genotype-Guided Protease Inhibitor Triple Therapy versus Standard of Care Treatment in Patients with Hepatitis C Genotypes 2 or 3 Infection. Public Health Genomics. 2014 Sep 18. [Epub ahead of print] PubMed PMID: 25247313.
Negrón ME, Kaplan GG, Barkema HW, et. al. Colorectal Cancer Surveillance in Patients with Inflammatory Bowel Disease and Primary Sclerosing Cholangitis: An Economic Evaluation. Inflamm Bowel Dis. 2014 Sep 16. [Epub ahead of print] PubMed PMID: 25230162.
Laramée P, Brodtkorb TH, Rahhali N, et. al. The cost-effectiveness and public health benefit of nalmefene added to psychosocial support for the reduction of alcohol consumption in alcohol-dependent patients with high/very high drinking risk levels: a Markov model. BMJ Open. 2014 Sep 16;4(9):e005376. PubMed PMID: 25227627.